Matrixx Initiatives, Inc. to Present at the William Blair & Company's Second Annual Small-Cap Growth Stock Conference
The Company will be presenting at 9:20 a.m. ET. To listen to the livepresentation via the Internet, go to http://www.matrixxinc.com and click onEvents & Presentations. Interested parties should login 15 minutes prior tothe event to register and to install Windows Media Player if necessary.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development and marketing ofover-the-counter healthcare products that utilize innovative drug deliverysystems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam(R)and Nasal Comfort(TM) products in the cough and cold category, and Xcid(TM)antacid in the digestive health category. The Company's flagship product,Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has beenclinically proven to reduce the duration and severity of the common cold. Instudies published in the October 2000 issue of ENT -- Ear, Nose and ThroatJournal, and separately in the January 2003 issue of QJM: An InternationalJournal of Medicine, the Zicam Cold Remedy product was shown to reduce theduration of the common cold. The Company also manufactures and markets a fullline of Zicam brand pharmaceuticals, including Zicam Cold Remedy Swabs(TM);Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam ColdRemedy RapidMelts(TM); Zicam Allergy Relief; Zicam Extreme Congestion Relief;Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptomrelief items. For more information regarding Matrixx products, go tohttp://www.Zicam.com. To find out more about Matrixx Initiatives, Inc.(Nasdaq: MTXX), visit our website at http://www.matrixxinc.com. Foradditional information, contact William Hemelt, Chief Financial Officer,602-385-8888, or Bill Barba, Treasurer, at 602-385-8881. Matrixx is located at8515 E. Anderson Dr., Scottsdale, Arizona 85255.
SOURCE Matrixx Initiatives, Inc.
You May Also Like